Previous 10 | Next 10 |
LAKE FOREST, Ill., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that Dr. David Wheadon has been appointed to the Company’s Board of Directors. Dr. Wheadon is a former senior executive of AstraZeneca plc. “David is a globally ...
LAKE FOREST, Ill., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the Annual Cantor Fitzgerald Global Healthcare Conference in a session scheduled for 12:35 p.m. ET, Friday, October 4, 2019 ...
The following slide deck was published by Assertio Therapeutics, Inc. in conjunction with this Read more ...
The Trump administration has allocated $1.8B to help states and local governments tackle opioid addiction in their respective areas. The funds will be distributed through Substance Abuse and Mental Health Services and the CDC for treatment and data gathering. More news on: Teva Pharmaceu...
An Oklahoma district court has ordered Johnson & Johnson (NYSE: JNJ ) to pay $572M over its role in the opioid epidemic there. One-time co-defendants Purdue Pharma and Teva Pharmaceutical Industries (NYSE: TEVA ) settled earlier for $270M and $85M, respectively. More news on: John...
Gainers : Cemtrex (NASDAQ: CETX ) +91% . SCWorx (NASDAQ: WORX ) +30% . Cheetah Mobile (NYSE: CMCM ) +27% . Endo International (NASDAQ: ENDP ) +26% . MOGU (NYSE: MOGU ) +18% . VIVUS (NASDAQ: VVUS ) +17% . Mereo BioPharma Group (NASDAQ: MREO ) +16% . Foresight Autonomous Holdings (NAS...
Endo International ( ENDP +18.4% ) is up on below-average volume in early trade on the heels of its announcement that subsidiaries Endo Pharmaceuticals, Endo Health Solutions, Par Pharmaceutical and Par Pharmaceutical Companies have agreed in principle to settle lawsuits brought by two c...
LAKE FOREST, Illinois, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the 17 th Annual Morgan Stanley Global Healthcare Conference in a session scheduled for 11:45 a.m. ET, Tuesday, Septembe...
Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 117 weeks of public selections as part of this ongoing live forward-testing. In...
Nano cap Assertio Therapeutics ( ASRT -46.6% ) is down on almost a 6x surge in volume in reaction to its generous exchange offer to holders of some of its outstanding 2.50% Convertible Notes due 2021. More news on: Assertio Therapeutics, Inc., Healthcare stocks news, Stocks on the...
News, Short Squeeze, Breakout and More Instantly...
Assertio Therapeutics Inc. Company Name:
ASRT Stock Symbol:
NASDAQ Market:
Assertio Therapeutics Inc. Website:
LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that it will rel...
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ASRT on July 3, 2024 06:04AM ET. ASRT was trading at $1.15 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief...